1,516 articles
Gerald Salen
Gerald Salen (1935–2020) was an American gastroenterologist and lipid metabolism researcher in New Jersey who defined cerebrotendinous xanthomatosis, sitosterolemia, and Smith-Lemli-Opitz syndrome, and pioneered chenodeoxycholic acid treatment.
Gerard Karsenty
Gerard Karsenty is a physician-scientist who chairs Genetics and Development at Columbia University, known for establishing that bone is an endocrine organ via osteocalcin, which regulates glucose homeostasis, male fertility, and cognition.
Gerard N. Burrow
Gerard Noel Burrow (1933–2013) was an American endocrinologist and expert on thyroid disease in pregnancy who served as the 14th dean of the Yale School of Medicine.
Gerd Assmann
Gerd Assmann is a German clinical chemist and atherosclerosis researcher, professor at the University of Münster, known for initiating and leading the PROCAM cardiovascular risk study.
Gerd Hasenfuß
Gerd Hasenfuß, born 1955 in Kehl, is a German cardiologist who led cardiology at Universitätsmedizin Göttingen from 1998 to 2024 and studied calcium handling in heart failure.
Gerd Heusch
Gerd Heusch is a German physician-scientist in cardiology, emeritus professor at the University of Duisburg-Essen and president of the North Rhine-Westphalian Academy of Sciences since 2025.
Geremia B. Bolli
Geremia B. Bolli, born 1947, is an Italian endocrinologist at the University of Perugia known for 1984 New England Journal of Medicine papers on the dawn phenomenon.
Gerhard Schüler
Gerhard Schüler, also spelled Gerhard Schuler, is a German cardiologist and long-serving clinic director at the Herzzentrum Leipzig, known for the IABP-SHOCK II cardiogenic shock trial.
Gerhard Steinbeck
Gerhard Steinbeck, born 1946 in Göttingen, is a German cardiologist known for trials on arrhythmias and risk stratification after myocardial infarction, including the IRIS trial.
Gervasio A. Lamas
Gervasio A. Lamas is a cardiologist who chairs medicine at Mount Sinai Medical Center in Miami Beach and led the MOST, SAVE PACe, and TACT trials.
Gian Carlo Viberti
Gian Carlo Viberti is a British diabetologist and Emeritus Professor of Diabetes at King's College London, known for research on microalbuminuria and diabetic kidney disease.
Gilbert R. Thompson
Gilbert R. Thompson (G. R. Thompson; 1932–2026) was a British physician and Professor of Clinical Lipidology at Imperial College London who pioneered plasma exchange and LDL apheresis for familial hypercholesterolaemia.
Gilbert Vassart
Gilbert Vassart, born 1944 in Brussels, is a Belgian physician-scientist at the Université Libre de Bruxelles whose laboratory cloned the TSH receptor in 1989 and showed its mutations cause hyperthyroidism.
Gilles Mithieux
Gilles Mithieux (born 1958) is a French physiologist and CNRS research director who leads the NUDICE unit in Lyon, known for establishing intestinal gluconeogenesis as a gut-to-brain signal controlling hunger and glucose metabolism.
Gilles Montalescot
Gilles Montalescot is a French cardiologist, professor at Sorbonne Université and cardiologist at Hôpital Pitié-Salpêtrière, who led major trials in acute coronary syndromes and antithrombotic therapy.
Gilles R. Dagenais
Gilles R. Dagenais, also published as Gilles Dagenais, is a Canadian cardiologist and epidemiologist at the IUCPQ in Quebec City, known for the HOPE-3 trial and PURE cohort studies.
Gillian L. Booth
Gillian L. Booth is a Canadian endocrinologist at St. Michael's Hospital in Toronto who studies how socioeconomic status, walkability, and health-care access shape diabetes risk and its cardiovascular complications.
Giovanna Liuzzo
Giovanna Liuzzo is an Italian cardiologist and physician-scientist at the Università Cattolica del Sacro Cuore in Rome, known for establishing that inflammation and T-cell immunity destabilize coronary plaques.
Giovanni Targher
Giovanni Targher (born 1966) is an Italian physician and clinical epidemiologist, professor of endocrinology at the University of Verona known for research on fatty liver disease.
Giraud V. Foster
Giraud V. Foster was an American endocrinologist whose 1964 Nature paper established that calcitonin, the calcium-lowering hormone, comes from the thyroid; he later directed the Johns Hopkins Program in Gynecology and Obstetrics.
Giulio Stefanini
Giulio Giuseppe Stefanini is an Italian interventional cardiologist and Professor of Cardiology at Humanitas University in Milan, known for his 2013 New England Journal review of drug-eluting stents.
Giuseppe Mancia
Giuseppe Mancia is an Italian hypertension researcher, Professor Emeritus at the University of Milano-Bicocca, who chaired the ESH/ESC hypertension guidelines and edited the Journal of Hypertension.
Glenn N. Levine
Glenn N. Levine is an American cardiologist, Master Clinician and Professor of Medicine at Baylor College of Medicine, known for chairing ACC/AHA guidelines on coronary intervention and antiplatelet therapy.
Gökhan S. Hotamışlıgil
Gökhan S. Hotamışlıgil is a physician-scientist at the Harvard T.H. Chan School of Public Health who studies how inflammation drives obesity and type 2 diabetes, and coined "metaflammation."
Goodarz Danaei
Goodarz Danaei is a physician and cardiovascular epidemiologist, Bernard Lown Professor at the Harvard T.H. Chan School of Public Health, known for the Globorisk model.
Gordon B. Cutler
Gordon B. Cutler, Jr. is an American endocrinologist who led the Section on Developmental Endocrinology at NIH's NICHD from 1983 to 1997, then worked with Eli Lilly.
Gordon F. Tomaselli
Gordon F. Tomaselli is an American cardiologist and cardiac electrophysiologist who spent 32 years at Johns Hopkins, leading its cardiology division, before becoming dean of Albert Einstein College of Medicine in 2018.
Gordon H. Williams
Gordon H. Williams is an American endocrinologist and Harvard Medical School professor at Brigham and Women's Hospital, known for describing hypertension with inappropriate aldosterone stimulation.
Gordon Keller
Gordon M. Keller is a Canadian stem cell biologist known for the 1997 discovery of the hemangioblast and for directing pluripotent stem cells into blood and heart cells.
Graeme I. Bell
Graeme I. Bell is an American-trained biochemist and human geneticist at the University of Chicago known for the genetics of diabetes, including the first positional cloning of calpain-10 in type 2 diabetes.